Lymphadenopathy other imaging findings: Difference between revisions
Jump to navigation
Jump to search
Kiran Singh (talk | contribs) |
No edit summary |
||
Line 6: | Line 6: | ||
==Overview== | ==Overview== | ||
[[Positron emission tomography]] ([[PET]]) is used to evaluate clinically diagnosed [[lymphadenopathy]]. | [[Positron emission tomography]] ([[PET]]) is used to evaluate clinically diagnosed [[lymphadenopathy]]. | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
[[Category:primary care]] | [[Category:primary care]] | ||
[[Category:Inflammations]] | [[Category:Inflammations]] | ||
Line 13: | Line 15: | ||
[[Category:Infectious disease]] | [[Category:Infectious disease]] | ||
[[Category:Hematology]] | [[Category:Hematology]] | ||
[[Category:Physical examination]] | [[Category:Physical examination]] | ||
[[Category:Needs content]] | [[Category:Needs content]] | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} |
Revision as of 17:33, 24 August 2015
Lymphadenopathy Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Lymphadenopathy other imaging findings On the Web |
American Roentgen Ray Society Images of Lymphadenopathy other imaging findings |
Risk calculators and risk factors for Lymphadenopathy other imaging findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Raviteja Guddeti, M.B.B.S. [2]
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Overview
Positron emission tomography (PET) is used to evaluate clinically diagnosed lymphadenopathy.